Ankylosing Spondylitis Global Market Report 2024

Global Ankylosing Spondylitis Market Report 2024

Ankylosing Spondylitis Global Market Report 2024 – By Treatment Type (Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biological Therapies, Steroids, Physical Therapies, Surgery), By Molecule (Biologics, Biosimilar, Small Molecules), By Route of Administration (Parenteral, Oral, Other Routes), By Application (Juveniles, Adults), By End User (Hospitals, Clinics, Research Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

Name: Ankylosing Spondylitis Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Ankylosing Spondylitis Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Ankylosing Spondylitis Global Market Report 2024

Proud Members Of

Ankylosing Spondylitis Market Definition

Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily affects the spine and sacroiliac joints (the joints connecting the lower spine to the pelvis). It involves inflammation of the joints and entheses and affects joints, leading to pain, stiffness, and progressive loss of mobility in the spine.

The main treatment of ankylosing spondylitis includes painkillers and non-steroidal anti-inflammatory drugs (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs), biological therapies, steroids, and physical therapies, surgery. Painkillers and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) refer to medications that block the production of certain chemicals in the body that cause pain and swelling, which are used in ankylosing spondylitis treatment to relieve pain and reduce inflammation. Biologics, biosimilars, and small molecules are administered through parenteral, oral, and other routes for applications in juveniles and adults by hospitals, clinics, research laboratories, and other end users.

Ankylosing Spondylitis Market Segmentation

The ankylosing spondylitis market covered in this report is segmented –

1) By Treatment Type: Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biological Therapies, Steroids, Physical Therapies, Surgery

2) By Molecule: Biologics, Biosimilar, Small Molecules

3) By Route of Administration: Parenteral, Oral, Other Routes

4) By Application: Juveniles, Adults

5) By End User: Hospitals, Clinics, Research Laboratories, Other End Users

Global Ankylosing Spondylitis Market Size 2023 to 2028: Graph

Ankylosing Spondylitis Market Size 2024 And Growth Rate

The ankylosing spondylitis market size has grown strongly in recent years. It will grow from $5.41 billion in 2023 to $5.86 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to hla-b27 discovery, biologic treatments development, pain management approaches, patient advocacy and awareness, nsaids and disease modifying drugs.

Ankylosing Spondylitis Market Growth Forecast

The ankylosing spondylitis market size is expected to see strong growth in the next few years. It will grow to $7.89 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to personalized medicine approach, novel biologics development, early intervention and screening, lifestyle and diet management, telemedicine and remote monitoring. Major trends in the forecast period include biosimilar availability, targeted pain therapies, patient-reported outcomes (pros) emphasis, community support programs, regenerative medicine exploration.

Book your 30 minutes free consultation with our research experts

Ankylosing Spondylitis Market Driver: Ankylosing Spondylitis Market Surges With The Growing Geriatric Population Worldwide

The increasing geriatric population is expected to propel the growth of the ankylosing spondylitis market going forward. The geriatric population refers to an increase in the proportion of elderly people due to changes in the age structure of a population. This demographic shift has increased the number and proportion of people over the age of 60. Ankylosing spondylitis treatment and drugs help to improve mobility and manage pain in the geriatric population having ankylosing spondylitis condition. For instance, in October 2022, according to World Health Organization, a Switzerland-based international public health organization, by 2030, 1 out of 6 people in the world will be aged more than 60 years or above, and in 2020, there was a rise in 1 billion aged people reaching to 1.4 billion. Therefore, the increasing geriatric population is driving the growth of the ankylosing spondylitis market.

Ankylosing Spondylitis Market Driver: Escalating Instances Of Autoimmune Diseases Propel The Ankylosing Spondylitis Market

The increase in instances of autoimmune diseases will boost the ankylosing spondylitis market going forward. Autoimmune diseases are a broad group of disorders characterized by an abnormal immune response in which the immune system mistakenly attacks and damages healthy cells, tissues, and organs. Autoimmune diseases, including ankylosing spondylitis, occur when the immune system mistakenly targets the body's own tissues, leading to inflammation and damage, with genetic predisposition and environmental factors contributing to the development of ankylosing spondylitis, a form of autoimmune arthritis primarily affecting the spine and pelvis. For instance, in May 2023, as per new population-based study by the University of Oxford, a UK-based research university, autoimmune disorders now affect about one in ten individuals. Therefore, the increase in instances of autoimmune diseases will drive the future growth of the ankylosing spondylitis market.

Global Ankylosing Spondylitis Market Major Players

Major companies operating in the ankylosing spondylitis market report are Pfizer Inc., Johnson & Johnson Pvt. Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Amgen Inc., Cedars-Sinai, Viatris Inc., Astellas Pharma Inc., Regeneron Pharmaceuticals Inc., AstraZeneca plc, UCB Inc., Cipla Inc., Zydus Lifesciences Limited, Celltrion Inc., Hetero Labs Ltd., UCSF Health, Janssen Biotech Inc., Sandoz International GmbH, Reliance Life Sciences Pvt. Ltd., Affibody Medical AB

Global Ankylosing Spondylitis Market Trend: Advancements In Therapeutic Options Drive Growth In The Ankylosing Spondylitis Market

The advancements in therapeutic options are a key trend gaining popularity in the ankylosing spondylitis market. Companies operating in ankylosing spondylitis are advancing new therapeutic options to sustain their position in the market. For instance, in December 2021, Pfizer Inc., a US-based pharmaceutical and biotechnology company received FDA approval for XELJANZ (tofacitinib) for the treatment of active ankylosing spondylitis. XELJANZ (tofacitinib) is a Janus kinase (JAK) inhibitor effective for five immuno-inflammatory conditions. This medication is effective against intolerance or inadequate response to one or more tumor necrosis factor (TNF) blockers. The XELJANZ (tofacitinib) does not require infusion or injection to deliver the medication.

Global Ankylosing Spondylitis Market Trend: Focus On Enzymatic And Cellular Assays For Targeted Therapies

Major companies operating in ankylosing spondylitis are focused on developing innovative drugs such as drugs based on enzymatic and cellular assays for the treatment of moderately to severely active rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohn’s disease, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Drugs based on enzymatic and cellular assays are pharmaceuticals developed and validated through testing their effects on specific enzymes or cell systems, enabling targeted and precise therapeutic interventions. For instance, in April 2022, AbbVie Inc., a US-based pharmaceutical company, received Food and Drug Administration (FDA) approval, this time for the treatment of ankylosing spondylitis (AS). RINVOQ, a selective JAK inhibitor undergoing investigation across various immune-mediated inflammatory diseases, exhibits heightened inhibitory potency for JAK-1 over JAK-2, JAK-3, and TYK-2 based on enzymatic and cellular assays.

Ankylosing Spondylitis Market Merger And Acquisition: Merck & Co. Inc. Boosts Portfolio With Acquisition Of Prometheus Biosciences Inc.

In April 2021, Merck & Co. Inc., a Germany-based biopharmaceutical, and technology company acquired Prometheus Biosciences Inc. for $10.8 billion. This acquisition broadens, diversifies, and strengthens Merck’s immunology pipeline by adding innovations and novel therapeutics. Prometheus Biosciences Inc. is a US-based biotechnology company and manufacturer of PRA023 used in the treatment of ankylosing spondylitis.

Regional Outlook For The Global Ankylosing Spondylitis Market

North America was the largest region in the ankylosing spondylitis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ankylosing spondylitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ankylosing spondylitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ankylosing spondylitis market consists of sales of nonsteroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs (DMARDs), tumor necrosis factor (TNF) inhibitors, interleukin inhibitors, and corticosteroids. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The ankylosing spondylitis market research report is one of a series of new reports from The Business Research Company that provides ankylosing spondylitis market statistics, including ankylosing spondylitis industry global market size, regional shares, competitors with an ankylosing spondylitis market share, detailed ankylosing spondylitis market segments, market trends and opportunities, and any further data you may need to thrive in the ankylosing spondylitis industry. This ankylosing spondylitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Ankylosing Spondylitis Market Report Forecast And Analysis

Report Attribute	Details
Market Size Value In 2024	$5.86 billion
Revenue Forecast In 2033	$7.89 billion
Growth Rate	CAGR of 7.7% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Treatment Type: Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biological Therapies, Steroids, Physical Therapies, Surgery 2) By Molecule: Biologics, Biosimilar, Small Molecules 3) By Route of Administration: Parenteral, Oral, Other Routes 4) By Application: Juveniles, Adults 5) By End User: Hospitals, Clinics, Research Laboratories, Other End Users
Regional Scope	Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc.; Johnson & Johnson Pvt. Ltd.; Merck & Co. Inc.; AbbVie Inc.; Novartis AG; Bristol-Myers Squibb; Eli Lilly and Company; Gilead Sciences Inc.; Boehringer Ingelheim International GmbH; Amgen Inc.; Cedars-Sinai; Viatris Inc.; Astellas Pharma Inc.; Regeneron Pharmaceuticals Inc.; AstraZeneca plc; UCB Inc.; Cipla Inc.; Zydus Lifesciences Limited; Celltrion Inc.; Hetero Labs Ltd.; UCSF Health; Janssen Biotech Inc.; Sandoz International GmbH; Reliance Life Sciences Pvt. Ltd.; Affibody Medical AB
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Ankylosing Spondylitis Market Characteristics

3. Ankylosing Spondylitis Market Trends And Strategies

4. Ankylosing Spondylitis Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global Ankylosing Spondylitis Market Size and Growth

5.1. Global Ankylosing Spondylitis Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Ankylosing Spondylitis Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Ankylosing Spondylitis Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Ankylosing Spondylitis Market Segmentation

6.1. Global Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)

Disease-Modifying Anti-Rheumatic Drugs (DMARDS)

Biological Therapies

Steroids

Physical Therapies

Surgery

6.2. Global Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Biologics

Biosimilars

Small Molecules

6.3. Global Ankylosing Spondylitis Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Parenteral

Oral

Other Routes

6.4. Global Ankylosing Spondylitis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Juveniles

Adults

6.5. Global Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Hospitals

Clinics

Research Laboratories

Other End Users

7. Ankylosing Spondylitis Market Regional And Country Analysis

7.1. Global Ankylosing Spondylitis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Ankylosing Spondylitis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Ankylosing Spondylitis Market

8.1. Asia-Pacific Ankylosing Spondylitis Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Ankylosing Spondylitis Market

9.1. China Ankylosing Spondylitis Market Overview

9.2. China Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Ankylosing Spondylitis Market

10.1. India Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Ankylosing Spondylitis Market

11.1. Japan Ankylosing Spondylitis Market Overview

11.2. Japan Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Ankylosing Spondylitis Market

12.1. Australia Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Ankylosing Spondylitis Market

13.1. Indonesia Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Ankylosing Spondylitis Market

14.1. South Korea Ankylosing Spondylitis Market Overview

14.2. South Korea Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Ankylosing Spondylitis Market

15.1. Western Europe Ankylosing Spondylitis Market Overview

15.2. Western Europe Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Ankylosing Spondylitis Market

16.1. UK Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Ankylosing Spondylitis Market

17.1. Germany Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Ankylosing Spondylitis Market

18.5. France Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.6. France Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.7. France Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Ankylosing Spondylitis Market

19.9. Italy Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.10. Italy Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.11. Italy Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Ankylosing Spondylitis Market

20.13. Spain Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.14. Spain Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.15. Spain Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Ankylosing Spondylitis Market

21.1. Eastern Europe Ankylosing Spondylitis Market Overview

21.2. Eastern Europe Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Ankylosing Spondylitis Market

22.1. Russia Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Ankylosing Spondylitis Market

23.1. North America Ankylosing Spondylitis Market Overview

23.2. North America Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Ankylosing Spondylitis Market

24.1. USA Ankylosing Spondylitis Market Overview

24.2. USA Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Ankylosing Spondylitis Market

25.1. Canada Ankylosing Spondylitis Market Overview

25.2. Canada Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Ankylosing Spondylitis Market

26.1. South America Ankylosing Spondylitis Market Overview

26.2. South America Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Ankylosing Spondylitis Market

27.1. Brazil Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Ankylosing Spondylitis Market

28.1. Middle East Ankylosing Spondylitis Market Overview

28.2. Middle East Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Ankylosing Spondylitis Market

29.1. Africa Ankylosing Spondylitis Market Overview

29.2. Africa Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Ankylosing Spondylitis Market Competitive Landscape And Company Profiles

30.1. Ankylosing Spondylitis Market Competitive Landscape

30.2. Ankylosing Spondylitis Market Company Profiles

30.2.1. Pfizer Inc.

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. Johnson & Johnson Pvt. Ltd.

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. Merck & Co. Inc.

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. AbbVie Inc.

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. Novartis AG

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Ankylosing Spondylitis Market Other Major And Innovative Companies

31.1. Bristol-Myers Squibb

31.2. Eli Lilly and Company

31.3. Gilead Sciences Inc.

31.4. Boehringer Ingelheim International GmbH

31.5. Amgen Inc.

31.6. Cedars-Sinai

31.7. Viatris Inc.

31.8. Astellas Pharma Inc.

31.9. Regeneron Pharmaceuticals Inc.

31.10. AstraZeneca plc

31.11. UCB Inc.

31.12. Cipla Inc.

31.13. Zydus Lifesciences Limited

31.14. Celltrion Inc.

31.15. Hetero Labs Ltd.

32. Global Ankylosing Spondylitis Market Competitive Benchmarking

33. Global Ankylosing Spondylitis Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Ankylosing Spondylitis Market

35. Ankylosing Spondylitis Market Future Outlook and Potential Analysis

35.1 Ankylosing Spondylitis Market In 2028 - Countries Offering Most New Opportunities

35.2 Ankylosing Spondylitis Market In 2028 - Segments Offering Most New Opportunities

35.3 Ankylosing Spondylitis Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Ankylosing Spondylitis Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 6: Global Ankylosing Spondylitis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 7: Global Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 8: Global Ankylosing Spondylitis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 9: Global Ankylosing Spondylitis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 10: Asia-Pacific, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 11: Asia-Pacific, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 12: Asia-Pacific, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 13: China, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 14: China, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 15: China, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 16: India, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 17: India, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 18: India, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 19: Japan, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 20: Japan, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 21: Japan, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 22: Australia, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 23: Australia, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 24: Australia, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 25: Indonesia, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 26: Indonesia, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 27: Indonesia, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 28: South Korea, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 29: South Korea, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 30: South Korea, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 31: Western Europe, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 32: Western Europe, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 33: Western Europe, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 34: UK, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 35: UK, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 36: UK, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 37: Germany, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 38: Germany, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 39: Germany, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 40: France, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 41: France, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 42: France, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 43: Italy, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 44: Italy, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 45: Italy, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 46: Spain, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 47: Spain, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 48: Spain, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 49: Eastern Europe, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 50: Eastern Europe, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 51: Eastern Europe, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 52: Russia, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 53: Russia, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 54: Russia, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 55: North America, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 56: North America, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 57: North America, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 58: USA, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 59: USA, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 60: USA, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 61: Canada, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 62: Canada, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 63: Canada, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 64: South America, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 65: South America, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 66: South America, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 67: Brazil, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 68: Brazil, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 69: Brazil, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 70: Middle East, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 71: Middle East, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 72: Middle East, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 73: Africa, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 74: Africa, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 75: Africa, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 76: Pfizer Inc. Financial Performance

Table 77: Johnson & Johnson Pvt. Ltd. Financial Performance

Table 78: Merck & Co. Inc. Financial Performance

Table 79: AbbVie Inc. Financial Performance

Table 80: Novartis AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2018-2023, $ Billion

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Figure 3: Global Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 4: Global Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 5: Global Ankylosing Spondylitis Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 6: Global Ankylosing Spondylitis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 7: Global Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 8: Global Ankylosing Spondylitis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 9: Global Ankylosing Spondylitis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 10: Asia-Pacific, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 11: Asia-Pacific, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 12: Asia-Pacific, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 13: China, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 14: China, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 15: China, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 16: India, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 17: India, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 18: India, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 19: Japan, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 20: Japan, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 21: Japan, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 22: Australia, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 23: Australia, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 24: Australia, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 25: Indonesia, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 26: Indonesia, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 27: Indonesia, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 28: South Korea, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 29: South Korea, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 30: South Korea, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 31: Western Europe, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 32: Western Europe, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 33: Western Europe, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 34: UK, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 35: UK, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 36: UK, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 37: Germany, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 38: Germany, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 39: Germany, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 40: France, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 41: France, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 42: France, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 43: Italy, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 44: Italy, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 45: Italy, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 46: Spain, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 47: Spain, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 48: Spain, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 49: Eastern Europe, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 50: Eastern Europe, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 51: Eastern Europe, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 52: Russia, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 53: Russia, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 54: Russia, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 55: North America, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 56: North America, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 57: North America, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 58: USA, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 59: USA, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 60: USA, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 61: Canada, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 62: Canada, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 63: Canada, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 64: South America, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 65: South America, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 66: South America, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 67: Brazil, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 68: Brazil, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 69: Brazil, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 70: Middle East, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 71: Middle East, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 72: Middle East, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 73: Africa, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 74: Africa, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 75: Africa, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 76: Pfizer Inc. Financial Performance

Figure 77: Johnson & Johnson Pvt. Ltd. Financial Performance

Figure 78: Merck & Co. Inc. Financial Performance

Figure 79: AbbVie Inc. Financial Performance

Figure 80: Novartis AG Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

How Will The Nuclear Medicine Market Grow In 2022?

What Is The Pediatric Imaging Market Overview In 2022?

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the medical tourism market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the clinical chemistry market market research report 2022 with industry size, share, segments and market growth

Personal Care Shower And Bath Global Market Report 2024 – By Product Type (Shower Cream or Gel, Bar Soap, Body Wash, Shower Oil, Bath Additives, Other Product Types), By Form (Solid, Gel and Jellies, Liquid, Other forms), By Distribution Channel (Supermarkets and Hypermarkets, Convenience Stores, Online Retail Stores, Other Distribution Channels), By End-Users (Men, Women) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Luxury Hair Care Products Global Market Report 2024 – By Product Type (Shampoos, Conditioners, Hair Coloring Products, Hair Styling Products, Hair Oil, Other Product Types), By Distribution Channel (Supermarkets and Hypermarkets, Departmental Stores, Specialty Stores, E-commerce, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Natural Skin Care Products Global Market Report 2024 – By Product (Facial Care, Body Care), By Type (Mass, Premium), By Distribution Channel (Direct Selling, Other Distribution Channels), By End Use (Men, Women, Children) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Organic Skincare Global Market Report 2024 – By Type (Facial Care, Body Care, Other Types), By Gender (Male, Female), By Distribution Channel (Supermarkets or Hypermarket, Convenience Stores, Specialist Stores, Online Retail Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Personal Care Ingredients Global Market Report 2024 – By Ingredients (Emollients, Surfactants, Emulsifiers, Rheology Modifiers, Conditioning Polymers, Other Ingredients), By Source (Natural Ingredients, Synthetic Ingredients), By Application (Skin Care, Hair Care, Oral Care, Cosmetics, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Retail And Wholesale Global Market Report 2024 – By Type (Retail, Wholesale), By Ownership (Retail Chain/Wholesale Chain, Independent Retailer/Independent Wholesalers), By Price Range (Premium, Mid Range, Economy), By Distribution Channel (Supermarkets/Hypermarkets, Convenience Stores, Department Stores, Specialty Stores, Online, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Hair Preparations Global Market Report 2024 – By Type (Hair Spray, Conditioner, Shampoo, Hair Oil, Hair Color, Other Types), By Gender (Male, Female, Unisex), By Based On Type (Organic, Chemical), By Distribution Channel (Hypermarkets/Supermarkets, Specialty Stores, Online Stores, Convenience Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Natural Hair Care Products Global Market Report 2024 – By Product Type (Shampoos, Conditioners, Oils And Serum, Gel And Wax, Hair Color, Other Product Types), By Gender (Men, Women, Other Genders), By Price Category (High Or Premium, Medium, Low), By Distribution Channel (Offline, Online) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the ankylosing spondylitis market?

How will the ankylosing spondylitis market drivers and restraints affect the ankylosing spondylitis market dynamics? What forces will shape the ankylosing spondylitis industry going forward?

The ankylosing spondylitis market major growth driver - Ankylosing Spondylitis Market Surges With The Growing Geriatric Population Worldwide. For further insights on the ankylosing spondylitis market, request a sample here

What is the forecast market size or the forecast market value of the ankylosing spondylitis market?

The ankylosing spondylitis market size has grown strongly in recent years. It will grow from $5.41 billion in 2023 to $5.86 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to hla-b27 discovery, biologic treatments development, pain management approaches, patient advocacy and awareness, nsaids and disease modifying drugs. The ankylosing spondylitis market size is expected to see strong growth in the next few years. It will grow to $7.89 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to personalized medicine approach, novel biologics development, early intervention and screening, lifestyle and diet management, telemedicine and remote monitoring. Major trends in the forecast period include biosimilar availability, targeted pain therapies, patient-reported outcomes (pros) emphasis, community support programs, regenerative medicine exploration. For further insights on the ankylosing spondylitis market, request a sample here

How is the ankylosing spondylitis market segmented?

The ankylosing spondylitis market is segmented
1) By Treatment Type: Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biological Therapies, Steroids, Physical Therapies, Surgery
2) By Molecule: Biologics, Biosimilar, Small Molecules
3) By Route of Administration: Parenteral, Oral, Other Routes
4) By Application: Juveniles, Adults
5) By End User: Hospitals, Clinics, Research Laboratories, Other End UsersFor further insights on the ankylosing spondylitis market, request a sample here

Which region has the largest share of the ankylosing spondylitis market? What are the other regions covered in the report?

North America was the largest region in the ankylosing spondylitis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ankylosing spondylitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the ankylosing spondylitis market, request a sample here.

Who are the major players in the ankylosing spondylitis market?

What are the key trends in the ankylosing spondylitis market?

Major trend in the ankylosing spondylitis market - Advancements In Therapeutic Options Drive Growth In The Ankylosing Spondylitis Market. For further insights on the ankylosing spondylitis market, request a sample here.

What are the major opportunities in the ankylosing spondylitis market? What are the strategies for the ankylosing spondylitis market?

For detailed insights on the major opportunities and strategies in the ankylosing spondylitis market, request a sample here.

How does the ankylosing spondylitis market relate to the overall economy and other similar markets?

For detailed insights on ankylosing spondylitis market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the ankylosing spondylitis industry?

For detailed insights on the mergers and acquisitions in the ankylosing spondylitis industry, request a sample here.

What are the key dynamics influencing the ankylosing spondylitis market growth? SWOT analysis of the ankylosing spondylitis market.

For detailed insights on the key dynamics influencing the ankylosing spondylitis market growth and SWOT analysis of the ankylosing spondylitis industry, request a sample here.